Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 156.914
Filter
1.
Carbohydr Polym ; 339: 122209, 2024 Sep 01.
Article in English | MEDLINE | ID: mdl-38823899

ABSTRACT

The escalating global health concern arises from chronic wounds induced by bacterial infections, posing a significant threat to individuals. Consequently, an imperative exist for the development of hydrogel dressings to facilitate prompt wound monitoring and efficacious wound management. To this end, pH-sensitive bromothymol blue (BTB) and pH-responsive drug tetracycline hydrochloride (TH) were introduced into the polysaccharide-based hydrogel to realize the integration of wound monitoring and controlled treatment. Polysaccharide-based hydrogels were formed via a Schiff base reaction by cross-linking carboxymethyl chitosan (CMCS) on an oxidized sodium alginate (OSA) skeleton. BTB was used as a pH indicator to monitor wound infection through visual color changes visually. TH could be dynamically released through the pH response of the Schiff base bond to provide effective treatment and long-term antibacterial activity for chronically infected wounds. In addition, introducing polylactic acid nanofibers (PLA) enhanced the mechanical properties of hydrogels. The multifunctional hydrogel has excellent mechanical, self-healing, injectable, antibacterial properties and biocompatibility. Furthermore, the multifaceted hydrogel dressing under consideration exhibits noteworthy capabilities in fostering the healing process of chronically infected wounds. Consequently, the research contributes novel perspectives towards the advancement of intelligent and expeditious bacterial infection monitoring and dynamic treatment platforms.


Subject(s)
Alginates , Anti-Bacterial Agents , Bandages , Chitosan , Hydrogels , Nanofibers , Wound Healing , Nanofibers/chemistry , Hydrogels/chemistry , Hydrogels/pharmacology , Wound Healing/drug effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Hydrogen-Ion Concentration , Chitosan/chemistry , Chitosan/analogs & derivatives , Chitosan/pharmacology , Alginates/chemistry , Animals , Staphylococcus aureus/drug effects , Tetracycline/chemistry , Tetracycline/pharmacology , Mice , Wound Infection/drug therapy , Polysaccharides/chemistry , Escherichia coli/drug effects , Schiff Bases/chemistry , Microbial Sensitivity Tests , Humans
2.
Carbohydr Polym ; 339: 122255, 2024 Sep 01.
Article in English | MEDLINE | ID: mdl-38823921

ABSTRACT

Mixed infectious vaginitis poses a serious threat to female reproductive health due to complex pathogenic factors, a long course and easy recurrence. Currently, antibiotic-based treatment methods are facing a crisis of drug resistance and secondary dysbiosis. Exploring effective drugs for the treatment of mixed vaginitis from Paeonia suffruticosa Andr., a natural traditional Chinese medicine with a long history of medicinal use, is a feasible treatment strategy. P. suffruticosa Andr. leaf extract (PLE) has significant anti-bacterial effects due to its rich content of polyphenols and flavonoids. The polyphenols in peony leaves have the potential to make carboxymethyl chitosan form in situ gel. In the current study, PLE and carboxymethyl chitosan were combined to develop another type of natural anti-bacterial anti-oxidant hydrogel for the treatment of mixed infectious vaginitis. Through a series of characterisations, CP had a three-dimensional network porous structure with good mechanical properties, high water absorption, long retention and a slow-release drug effect. The mixed infectious vaginitis mouse model induced by a mixture of pathogenic bacteria was used to investigate the therapeutic effects of CP in vivo. The appearance of the vagina, H&E colouring of the tissue and inflammatory factors (TNF-α, IL-6) confirm the good anti-vaginal effect of CP. Therefore, CP was expected to become an ideal effective strategy to improve mixed infection vaginitis due to its excellent hydrogel performance and remarkable ability to regulate flora.


Subject(s)
Anti-Bacterial Agents , Chitosan , Hydrogels , Paeonia , Plant Extracts , Plant Leaves , Chitosan/chemistry , Chitosan/pharmacology , Chitosan/analogs & derivatives , Female , Animals , Hydrogels/chemistry , Hydrogels/pharmacology , Plant Leaves/chemistry , Mice , Plant Extracts/chemistry , Plant Extracts/pharmacology , Paeonia/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/therapeutic use , Vaginosis, Bacterial/drug therapy , Vaginosis, Bacterial/microbiology , Antioxidants/pharmacology , Antioxidants/chemistry
3.
HIV Res Clin Pract ; 25(1): 2359791, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38829186

ABSTRACT

BACKGROUND: The global shift in healthcare during the COVID-19 pandemic led to challenges in the care of people living with HIV. METHODS: We conducted a retrospective study that aimed to delineate sociodemographic, clinical characteristics and outcomes, of people living with HIV diagnosed with ocular syphilis. RESULTS: Fifty-three people living with HIV were identified with ocular syphilis. Thirty-eight (71.6%) presented ocular symptoms. Twenty-three (43.3%) underwent lumbar puncture, 5 (9.4%) were positive for neurosyphilis. Forty-seven (88.6%) received treatment, 32 (68%) received standard treatment with aqueous crystalline penicillin G, and 15 (31.9%) were treated with alternative regimens due to the impossibility of hospitalization. Six (11.3%) individuals were lost to follow-up and/or did not receive treatment. Eighteen (56.2%) out of 32 individuals in the aqueous crystalline penicillin G group experienced serological response, 5 (15.6%) experienced treatment failure, and 9 (28.1%) were lost to follow-up. In the alternative therapy group, 12 out of 15 individuals (80%) experienced serological response. One (6.7%) experienced treatment failure, and 2 (13.3%) were lost to follow-up. CONCLUSIONS: During the COVID-19 health emergency in Mexico, alternative treatments for ocular syphilis demonstrated favorable clinical outcomes amid challenges in accessing hospitalization.


Subject(s)
COVID-19 , HIV Infections , Syphilis , Humans , Male , Female , Retrospective Studies , COVID-19/epidemiology , COVID-19/complications , Adult , HIV Infections/drug therapy , HIV Infections/complications , Middle Aged , Syphilis/drug therapy , Syphilis/complications , Syphilis/epidemiology , SARS-CoV-2 , Anti-Bacterial Agents/therapeutic use , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/drug therapy , Treatment Outcome , Neurosyphilis/drug therapy , Neurosyphilis/complications , Neurosyphilis/epidemiology , Penicillin G/therapeutic use
4.
J Endourol ; 38(6): 598-604, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38829325

ABSTRACT

Introduction: There are minimal data to guide antibiotic management of patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia. Specifically, management of high-risk patients who are catheter dependent or have positive preoperative urine cultures varies widely. We aimed to evaluate the effect of preoperative antibiotic duration on infectious complications in high-risk patients undergoing HoLEP. Methods: A multi-institutional retrospective review of patients undergoing HoLEP between 2018 and 2023 at five institutions was performed. Patients were defined as high risk if they were catheter-dependent (indwelling urethral catheter, self-catheterization, or suprapubic tube) or had a positive preoperative urine culture. These patients were categorized into long course (>3 days) or short course (≤3 days) of preoperative antibiotics. The primary outcome was 30-day infectious complications defined as a positive urine culture with symptoms. A t-test or Wilcoxon rank-sum test was used for continuous variables and Fisher's exact test was used for categorical variables. Logistic regression analysis was conducted to identify associations with infectious complications. Results: Our cohort included 407 patients, of which 146 (36%) and 261 (64%) were categorized as short course and long course of preoperative antibiotics, respectively. Median preoperative antibiotic duration was 1 day (interquartile range [IQR]: 0, 3 days) and 7 days (IQR: 5, 7 days) in the short and long cohorts, respectively. Thirty-day postoperative infectious complications occurred in 11 (7.6%) patients who received a short course of antibiotics and 5 (1.9%) patients who received a long course of antibiotics (odds ratio 0.24, 95% confidence interval 0.07-0.67; p = 0.009). Variables such as age, positive urine culture, and postoperative antibiotic duration were not significantly associated with postoperative infection after propensity score weighting. Conclusion: In high-risk patients undergoing HoLEP, infectious complications were significantly lower with a long course vs short course of antibiotics. Further prospective trials are needed to identify optimal preoperative antibiotic regimens.


Subject(s)
Anti-Bacterial Agents , Antibiotic Prophylaxis , Lasers, Solid-State , Preoperative Care , Prostatic Hyperplasia , Humans , Male , Aged , Retrospective Studies , Lasers, Solid-State/therapeutic use , Anti-Bacterial Agents/therapeutic use , Prostatic Hyperplasia/surgery , Antibiotic Prophylaxis/methods , Middle Aged , Urinary Tract Infections , Risk Factors , Postoperative Complications/etiology , Aged, 80 and over , Prostatectomy/methods , Prostatectomy/adverse effects , Prostate/surgery
5.
Am J Case Rep ; 25: e943953, 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38831580

ABSTRACT

BACKGROUND Peritoneal dialysis (PD) serves as a critical renal replacement therapy for individuals with end-stage renal disease (ESRD), leveraging the peritoneum for fluid and substance exchange. Despite its effectiveness, PD is marred by complications such as peritonitis, which significantly impacts patient outcomes. The novelty of our report lies in the presentation of a rare case of PD-associated peritonitis caused by 2 unusual pathogens, emphasizing the importance of rigorous infection control measures. CASE REPORT We report on an 80-year-old African-American female patient with ESRD undergoing PD, who was admitted twice within 8 months for non-recurring episodes of peritonitis. These episodes were attributed to the rare pathogens Achromobacter denitrificans/xylosoxidans and Carbapenem-resistant Acinetobacter baumannii. Despite presenting with similar symptoms during each episode, such as abdominal pain and turbid dialysis effluent, the presence of these uncommon bacteria highlights the intricate challenges in managing infections associated with PD. The treatment strategy encompassed targeted antibiotic therapy, determined through susceptibility testing. Notably, the decision to remove the PD catheter followed extensive patient education, ensuring the patient comprehended the rationale behind this approach. This crucial step, along with the subsequent shift to hemodialysis, was pivotal in resolving the infection, illustrating the importance of patient involvement in the management of complex PD-related infections. CONCLUSIONS This case underscores the complexities of managing PD-associated peritonitis, particularly with uncommon and resistant bacteria. It emphasizes the importance of rigorous infection control measures, the need to consider atypical pathogens, and the critical role of patient involvement in treatment decisions. Our insights advocate for a more informed approach to handling such infections, aiming to reduce morbidity and improve patient outcomes. The examination of the literature on recurrent peritonitis and treatment strategies provides key perspectives for navigating these challenging cases effectively.


Subject(s)
Kidney Failure, Chronic , Peritoneal Dialysis , Peritonitis , Humans , Peritonitis/microbiology , Peritonitis/etiology , Female , Aged, 80 and over , Peritoneal Dialysis/adverse effects , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , Acinetobacter baumannii , Achromobacter denitrificans , Anti-Bacterial Agents/therapeutic use , Gram-Negative Bacterial Infections/diagnosis , Acinetobacter Infections/drug therapy , Practice Guidelines as Topic
6.
PLoS One ; 19(6): e0304576, 2024.
Article in English | MEDLINE | ID: mdl-38829879

ABSTRACT

OBJECTIVE: The prevalence of syphilis in Zambia remains high and is a critical public health concern. The Zambian Ministry of Health recommends universal screening and same-day treatment for syphilis in pregnancy, yet the syphilis screening rate is low, and treatment is poorly documented. The goal of this study was to document syphilis treatment rates and associated factors among pregnant women in care in Zambia. METHODS: This retrospective cohort study included pregnant women diagnosed with syphilis according to rapid plasma reagin (RPR) screening during routine antenatal care (ANC) in Lusaka, Zambia in 2018-2019. The main outcome of interest was lack of documented BPG treatment during pregnancy. Additional information about pregnancy and neonatal outcomes, partner referral for therapy, and facility level stockout data were included. Patient characteristics were compared by treatment status using Pearson Chi-Square Test and logistic regression models were created to estimate the association between individual level-factors, facility type, and lack of BPG treatment. A Cochran-Mantel-Haenszel test was used to evaluate facility-level data with significance set at p<0.05. RESULTS: Among 1,231 pregnant women who screened positive for syphilis at clinic, 643 (52%) lacked documented antibiotic treatment at the facility. BPG was the only antibiotic used to treat syphilis in the cohort and 8% of sex partners had evidence of referral for therapy. Preterm delivery rates were higher in women without documented BPG (43% vs 32%; p = 0.003). In adjusted models, only calendar year and hospital facility type were associated with lack of treatment. At the facility level, annual syphilis screening rates ranged from 37-65% and most (7/10) clinics reported at least one stockout of BPG. CONCLUSION: Treatment rates for syphilis in pregnancy in Zambia were low and BPG medication stockouts at the facility level were common. A consistent supply of BPG at all ANC facilities is needed to facilitate timely treatment and improve birth outcomes.


Subject(s)
Penicillin G Benzathine , Pregnancy Complications, Infectious , Prenatal Care , Syphilis , Humans , Female , Pregnancy , Syphilis/drug therapy , Syphilis/epidemiology , Syphilis/diagnosis , Zambia/epidemiology , Penicillin G Benzathine/therapeutic use , Adult , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/epidemiology , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Young Adult , Adolescent
7.
Eur J Gastroenterol Hepatol ; 36(7): 916-923, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38829944

ABSTRACT

Infections significantly increase mortality in acute liver failure (ALF) patients, and there are no risk prediction models for early diagnosis and treatment of infections in ALF patients. This study aims to develop a risk prediction model for bacterial infections in ALF patients to guide rational antibiotic therapy. The data of ALF patients admitted to the Second Hospital of Hebei Medical University in China from January 2017 to January 2022 were retrospectively analyzed for training and internal validation. Patients were selected according to the updated 2011 American Association for the Study of Liver Diseases position paper on ALF. Serological indicators and model scores were collected within 24 h of admission. New models were developed using the multivariate logistic regression analysis. An optimal model was selected by receiver operating characteristic (ROC) analysis, Hosmer-Lemeshow test, the calibration curve, the Brier score, the bootstrap resampling, and the decision curve analysis. A nomogram was plotted to visualize the results. A total of 125 ALF patients were evaluated and 79 were included in the training set. The neutrophil-to-lymphocyte ratio and sequential organ failure assessment (SOFA) were integrated into the new model as independent predictive factors. The new SOFA-based model outperformed other models with an area under the ROC curve of 0.799 [95% confidence interval (CI): 0.652-0.926], the superior calibration and predictive performance in internal validation. High-risk individuals with a nomogram score ≥26 are recommended for antibiotic therapy. The new SOFA-based model demonstrates high accuracy and clinical utility in guiding antibiotic therapy in ALF patients.


Subject(s)
Anti-Bacterial Agents , Bacterial Infections , Liver Failure, Acute , Nomograms , Organ Dysfunction Scores , ROC Curve , Humans , Female , Male , Liver Failure, Acute/diagnosis , Middle Aged , Bacterial Infections/diagnosis , Bacterial Infections/drug therapy , Risk Assessment , Retrospective Studies , Adult , Anti-Bacterial Agents/therapeutic use , Risk Factors , China/epidemiology , Predictive Value of Tests , Neutrophils , Reproducibility of Results , Lymphocyte Count
9.
BMJ Paediatr Open ; 8(1)2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38830724

ABSTRACT

BACKGROUND: Partial or complete thymectomy is routinely performed in paediatric open-heart surgeries when treating congenital heart defects. Whether or not thymectomised children require systematic immunological monitoring later in life is unknown. The objective of this study was to investigate the effects of preoperatively and postoperatively used antibiotics, hospitalisation and surgical complications on self-reported immunological vulnerability in paediatric patients with early thymectomy to better recognise the patients who could benefit from immunological follow-up in the future. METHODS: We conducted a retrospective cohort study, including 98 children and adolescents aged 1-15 years, who had undergone an open-heart surgery and thymectomy in infancy and who had previously answered a survey regarding different immune-mediated symptoms and diagnoses. We performed a comprehensive chart review of preoperative and postoperative factors from 1 year preceding and 1 year following the open-heart surgery and compared the participants who had self-reported symptoms of immunological vulnerability to those who had not. RESULTS: The median age at primary open-heart surgery and thymectomy was 19.5 days in the overall study population (60% men, n=56) and thymectomies mainly partial (80%, n=78). Broad-spectrum antibiotics were more frequently used preoperatively in participants with self-reported immunological vulnerability (OR=3.05; 95% CI 1.01 to 9.23). This group also had greater overall use of antibiotics postoperatively (OR=3.21; 95% CI 1.33 to 7.76). These findings were more pronounced in the subgroup of neonatally operated children. There was no statistically significant difference in the duration of intensive care unit stay, hospitalisation time, prevalence of severe infections, surgical complications or glucocorticoid use between the main study groups. CONCLUSION: Antimicrobial agents were more frequently used both preoperatively and postoperatively in thymectomised children with self-reported immunological vulnerability after thymectomy. Substantial use of antimicrobial agents early in life should be considered a potential risk factor for increased immunological vulnerability when evaluating the significance of immune-mediated symptom occurrence in thymectomised paediatric patients.


Subject(s)
Anti-Bacterial Agents , Cardiac Surgical Procedures , Heart Defects, Congenital , Hospitalization , Postoperative Complications , Self Report , Thymectomy , Humans , Male , Retrospective Studies , Thymectomy/adverse effects , Female , Child , Infant , Child, Preschool , Adolescent , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/adverse effects , Cardiac Surgical Procedures/adverse effects , Postoperative Complications/epidemiology , Heart Defects, Congenital/surgery , Hospitalization/statistics & numerical data , Infant, Newborn
10.
BMJ Open ; 14(6): e085743, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38830743

ABSTRACT

OBJECTIVE: To assess antibiotic prescribing practice and its determinants among outpatient prescriptions dispensed to the elderly population. DESIGN: A prescription-based, cross-sectional study. SETTING: Six community chain pharmacies in Asmara, Eritrea. PARTICIPANTS: All outpatient prescriptions dispensed to the elderly population (aged 65 and above) in the six community chain pharmacies in Asmara, Eritrea. DATA COLLECTION AND ANALYSIS: Data were collected retrospectively, between 16 June 2023 and 16 July 2023. Antibiotic prescribing practice was assessed using the 2023 World Health Organization (WHO) Access, Watch and Reserve (AWaRe) classification system. Descriptive statistics and logistic regression were performed using IBM SPSS (V.26.0). P values less than 0.05 were considered as significant. RESULTS: Of the 2680 outpatient prescriptions dispensed to elderly population, 35.8% (95% CI: 34.0, 37.6) contained at least one antibiotic. Moreover, a total of 1061 antibiotics were prescribed to the elderly population. The most commonly prescribed antibiotics were ciprofloxacin (n=322, 30.3%) and amoxicillin/clavulanic acid (n=145, 13.7%). The Access category accounted for the majority of antibiotics (53.7%) with 32.1% from the Watch category. Prescriber qualification (Adjusted Odds Ratio (AOR)= 0.60, 95% CI: 0.44, 0.81) and polypharmacy (AOR= 2.32, 95% CI: 1.26, 4.27) were significant determinants of antibiotic prescribing in the elderly population. Besides, sex (AOR=0.74, 95% CI: 0.56, 0.98), prescriber qualification (AOR=0.49, 95% CI: 0.30 to0.81) and level of health facility (AOR 0.52, 95% CI 0.34 to 0.81) were significant determinants of a Watch antibiotic prescription. CONCLUSION: Antibiotics were prescribed to a considerable number of the elderly population, with more than half of them falling into the Access category. Further efforts by policy-makers are needed to promote the use of Access antibiotics while reducing the use of Watch antibiotics to mitigate risks associated with antimicrobial resistance.


Subject(s)
Anti-Bacterial Agents , Drug Prescriptions , Practice Patterns, Physicians' , Humans , Eritrea , Cross-Sectional Studies , Aged , Anti-Bacterial Agents/therapeutic use , Male , Female , Practice Patterns, Physicians'/statistics & numerical data , Drug Prescriptions/statistics & numerical data , Aged, 80 and over , Retrospective Studies , Outpatients/statistics & numerical data , World Health Organization , Pharmacies/statistics & numerical data , Logistic Models , Polypharmacy
11.
Sci Rep ; 14(1): 12737, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38830922

ABSTRACT

The COVID-19 pandemic has altered the infection landscape for many pathogens. This retrospective study aimed to compare Haemophilus influenzae (H. influenzae) infections in pediatric CAP patients hospitalized before (2018-2019) and during (2020-2022) the COVID-19 pandemic. We analyzed the clinical epidemiology and antimicrobial resistance (AMR) patterns of H. influenzae from a tertiary hospital in southwest China. A total of 986 pediatric CAP patients with H. influenzae-associated infections were included. Compared to 2018, the positivity rate increased in 2019 but dropped significantly in 2020. Although it rose in the following 2 years, the rate in 2022 remained significantly lower than in 2019. Patients' age during the pandemic was significantly higher than in 2018 and 2019, while gender composition remained similar across both periods. Notably, there were significant changes in co-infections with several respiratory pathogens during the pandemic. Resistance rates of H. influenzae isolates to antibiotics varied, with the highest resistance observed for ampicillin (85.9%) and the lowest for cefotaxime (0.0%). Resistance profiles to various antibiotics underwent dramatic changes during the COVID-19 pandemic. Resistance to amoxicillin-clavulanate, cefaclor, cefuroxime, trimethoprim-sulfamethoxazole, and the proportion of multi-drug resistant (MDR) isolates significantly decreased. Additionally, MDR isolates, alongside isolates resistant to specific drugs, were notably prevalent in ampicillin-resistant and ß-lactamase-positive isolates. The number of pediatric CAP patients, H. influenzae infections, and isolates resistant to certain antibiotics exhibited seasonal patterns, peaking in the winter of 2018 and 2019. During the COVID-19 pandemic, sharp decreases were observed in February 2020, and there was no resurgence in December 2022. These findings indicate that the COVID-19 pandemic has significantly altered the infection spectrum of H. influenzae in pediatric CAP patients, as evidenced by shifts in positivity rate, demographic characteristics, respiratory co-infections, AMR patterns, and seasonal trends.


Subject(s)
Anti-Bacterial Agents , COVID-19 , Community-Acquired Infections , Haemophilus Infections , Haemophilus influenzae , Humans , COVID-19/epidemiology , COVID-19/complications , Male , Female , Haemophilus influenzae/drug effects , Haemophilus influenzae/isolation & purification , Child , Child, Preschool , Haemophilus Infections/epidemiology , Haemophilus Infections/drug therapy , Haemophilus Infections/microbiology , Retrospective Studies , Community-Acquired Infections/epidemiology , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Infant , China/epidemiology , Anti-Bacterial Agents/therapeutic use , Hospitalization , Adolescent , Pandemics , Coinfection/epidemiology , Coinfection/drug therapy , Coinfection/microbiology , SARS-CoV-2/isolation & purification , SARS-CoV-2/drug effects , Drug Resistance, Bacterial
12.
Sci Rep ; 14(1): 12652, 2024 06 02.
Article in English | MEDLINE | ID: mdl-38825623

ABSTRACT

Excessive and improper use of antibiotics causes antimicrobial resistance which is a major threat to global health security. Hospitals in sub-Saharan Africa (SSA) has the highest prevalence of antibiotic use. This systematic review and meta-analysis aimed to determine the pooled point prevalence (PPP) of evidence-based antimicrobial use among hospitalized patients in SSA. Literature was retrieved from CINAHL, EMBASE, Google Scholar, PubMed, Scopus, and Web of Science databases. Meta-analysis was conducted using STATA version 17. Forest plots using the random-effect model were used to present the findings. The heterogeneity and publication bias were assessed using the I2 statistics and Egger's test. The protocol was registered in PROSPERO with code CRD42023404075. The review was conducted according to PRISMA guidelines. A total of 26, 272 study participants reported by twenty-eight studies published from 10 countries in SSA were included. The pooled point prevalence of antimicrobial use in SSA were 64%. The pooled estimate of hospital wards with the highest antibiotic use were intensive care unit (89%). The pooled prevalence of the most common clinical indication for antibiotic use were community acquired infection (41%). The pooled point prevalence of antimicrobial use among hospitalized patients were higher in SSA. Higher use of antibiotics was recorded in intensive care units. Community acquired infection were most common clinical case among hospitalized patients. Health systems in SSA must design innovative digital health interventions to optimize clinicians adhere to evidence-based prescribing guidelines and improve antimicrobial stewardship.


Subject(s)
Hospitalization , Humans , Africa South of the Sahara/epidemiology , Prevalence , Hospitalization/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Antimicrobial Stewardship
13.
J Korean Med Sci ; 39(21): e172, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38832477

ABSTRACT

BACKGROUND: We aimed to analyze the effects of an antimicrobial stewardship program (ASP) on the proportion of antimicrobial-resistant pathogens in bacteremia, antimicrobial use, and mortality in pediatric patients. METHODS: A retrospective single-center study was performed on pediatric inpatients under 19 years old who received systemic antimicrobial treatment from 2001 to 2019. A pediatric infectious disease attending physician started ASP in January 2008. The study period was divided into the pre-intervention (2001-2008) and the post-intervention (2009-2019) periods. The amount of antimicrobial use was defined as days of therapy per 1,000 patient-days, and the differences were compared using delta slope (= changes in slopes) between the two study periods by an interrupted time-series analysis. The proportion of resistant pathogens and the 30-day overall mortality rate were analyzed by the χ². RESULTS: The proportion of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia increased from 17% (39 of 235) in the pre-intervention period to 35% (189 of 533) in the post-intervention period (P < 0.001). The total amount of antimicrobial use significantly decreased after the introduction of ASP (delta slope value = -16.5; 95% confidence interval [CI], -30.6 to -2.3; P = 0.049). The 30-day overall mortality rate in patients with bacteremia did not increase, being 10% (55 of 564) in the pre-intervention and 10% (94 of 941) in the post-intervention period (P = 0.881). CONCLUSION: The introduction of ASP for pediatric patients reduced the delta slope of the total antimicrobial use without increasing the mortality rate despite an increased incidence of ESBL-producing gram-negative bacteremia.


Subject(s)
Anti-Bacterial Agents , Antimicrobial Stewardship , Bacteremia , Interrupted Time Series Analysis , Klebsiella pneumoniae , Humans , Retrospective Studies , Child , Bacteremia/drug therapy , Bacteremia/mortality , Bacteremia/microbiology , Female , Male , Child, Preschool , Anti-Bacterial Agents/therapeutic use , Infant , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Adolescent , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Hospitals, Pediatric
15.
Wiad Lek ; 77(3): 437-444, 2024.
Article in English | MEDLINE | ID: mdl-38691784

ABSTRACT

OBJECTIVE: Aim: To document the clinical patterns of antibiotic prescriptions in government hospitals, where the majority of physicians possess a degree-based training. PATIENTS AND METHODS: Materials and Methods: A Retrospective cross section study carried out between 1/7/2022 and April 2023 that enrolling 300 patients from governmental hospitals from different provinces of Central and northern Iraq. The research form contained 15 fields divided into three sections. The first section contains social information such as age, gender, field of work, Residence and education. The second part consists of diagnosis and lab. Finding. The third part related to antibiotic uses: Number of AB prescribed, duration of using, type of use, route of administration, AB interaction, dose administration of AB, indication of Ab, and Class of AB. RESULTS: Results: A total of 300 eligible patients, 165 patients (55.0%) were male and 135 (45.0%) were female, patients were <20 years ages were 117 (39.0%), 25 (8.3%) from the 20-29 years age group, 40-49 years ages were 28 (9.3%) and >50 years ages were 105 (35.0%) were which belong to the pediatric population. The 198 patients (66.0%) were used cephalosporins and 106 (53.5%) of them used alone. A 13-19% percentage of patients had used penicillin, carbapenem, anti-fungal, and aminoglycoside in combination form. CONCLUSION: Conclusions: The implementation of clinical guidelines, the provision of direct instruction, and the regular dissemination of antibiogram data have the potential to encourage a more judicious consumption of antibiotics.


Subject(s)
Anti-Bacterial Agents , Humans , Iraq , Female , Male , Adult , Middle Aged , Retrospective Studies , Young Adult , Cross-Sectional Studies , Anti-Bacterial Agents/therapeutic use , Hospitals, Public/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data
16.
Wiad Lek ; 77(3): 608-612, 2024.
Article in English | MEDLINE | ID: mdl-38691808

ABSTRACT

A case report of Jarisch-Herxheimer (JHR) reaction on a 10th day of Leptospirosis caused by Leptospira Pomona. JHR occurs as a complication of an antibiotic treatment of various spirochetes and may lead to respiratory distress syndrome, renal failure, hepatic insufficiency, and multiple organ failure. This case represents a skin and cardio-vascular form of JHR with no lung involvement. The patient was treated with benzylpenicillin and low dexamethasone doses for 5th day of the disease with a shift to ceftriaxone and high doses of methylprednisolone. The fastest diagnosis of a sporadic zoonotic disease, early start of antibiotic therapy, and adequate doses of corticosteroids are key to the successful treatment of leptospirosis.


Subject(s)
Anti-Bacterial Agents , Leptospirosis , Humans , Leptospirosis/drug therapy , Leptospirosis/complications , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/adverse effects , Male , Leptospira/isolation & purification , Ceftriaxone/therapeutic use , Ceftriaxone/adverse effects , Adult , Methylprednisolone/therapeutic use , Methylprednisolone/administration & dosage , Dexamethasone/therapeutic use , Dexamethasone/adverse effects
17.
Low Urin Tract Symptoms ; 16(3): e12515, 2024 May.
Article in English | MEDLINE | ID: mdl-38693055

ABSTRACT

OBJECTIVES: To investigate factors associated with symptomatic urinary tract infection (sUTI) in persons with chronic spinal cord lesion (SCL) who were using single-use catheters for intermittent self-catheterization (ISC). METHODS: Among respondents to an internet survey on the burden of illness on persons with SCL who were considered to be able to perform ISC, 111 persons using single-use catheters were included to examine factors associated with self-reported sUTI by univariate as well as multivariable analysis. RESULTS: The incidence of sUTI was significantly higher in males than in females (56.9% vs. 31.6%, p = .011), persons with stocks of antibiotics than those without it (82.9% vs. 28.6%, p < .011), and persons with more frequent bleeding during catheterization than those with less frequent bleeding (100% vs. 46.5%, p = .036). The incidence did not significantly differ between respective groups when various variables were evaluated by other characteristics of the participants, adherence to ISC procedures, and complications. On multivariable analysis, male gender and stocks of antibiotics were significant independent factors for sUTI. CONCLUSIONS: Male gender and stocks of antibiotics were associated with sUTI in persons with SCL who were performing ISC with single-use catheters.


Subject(s)
Anti-Bacterial Agents , Intermittent Urethral Catheterization , Spinal Cord Injuries , Urinary Tract Infections , Humans , Male , Female , Urinary Tract Infections/etiology , Urinary Tract Infections/epidemiology , Middle Aged , Adult , Intermittent Urethral Catheterization/adverse effects , Intermittent Urethral Catheterization/instrumentation , Spinal Cord Injuries/complications , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Incidence , Sex Factors , Urinary Catheters/adverse effects , Risk Factors , Aged , Urinary Catheterization/adverse effects , Urinary Catheterization/instrumentation
18.
J Antimicrob Chemother ; 79(5): 959-961, 2024 May 02.
Article in English | MEDLINE | ID: mdl-38693426

ABSTRACT

Community-acquired pneumonia continues to be one of the most common causes of morbidity and mortality due to infectious disease. The aetiologies, clinical presentations, diagnostic modalities and therapeutic options are changing and outpacing the creation of management guidelines. This educational article summarizes a roundtable activity sponsored by an unrestricted educational grant by Paratek that included US experts discussing these changes and identifying gaps in the current guidelines.


Subject(s)
Community-Acquired Infections , Pneumonia , Practice Guidelines as Topic , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Humans , United States , Pneumonia/diagnosis , Pneumonia/therapy , Pneumonia/drug therapy , Anti-Bacterial Agents/therapeutic use
19.
Front Cell Infect Microbiol ; 14: 1297312, 2024.
Article in English | MEDLINE | ID: mdl-38690325

ABSTRACT

Background: During the coronavirus disease 2019 (COVID-19) pandemic, in patients treated for SARS-CoV-2 infection, infections with the Klebsiella pneumoniae bacteria producing New Delhi metallo-B-lactamase (NDM) carbapenemase in the USA, Brazil, Mexico, and Italy were observed, especially in intensive care units (ICUs). This study aimed to assess the impact of Klebsiella pneumoniae NDM infection and other bacterial infections on mortality in patients treated in ICUs due to COVID-19. Methods: The 160 patients who qualified for the study were hospitalized in ICUs due to COVID-19. Three groups were distinguished: patients with COVID-19 infection only (N = 72), patients with COVID-19 infection and infection caused by Klebsiella pneumoniae NDM (N = 30), and patients with COVID-19 infection and infection of bacterial etiology other than Klebsiella pneumoniae NDM (N = 58). Mortality in the groups and chosen demographic data; biochemical parameters analyzed on days 1, 3, 5, and 7; comorbidities; and ICU scores were analyzed. Results: Bacterial infection, including with Klebsiella pneumoniae NDM type, did not elevate mortality rates. In the group of patients who survived the acute phase of COVID-19 the prolonged survival time was demonstrated: the median overall survival time was 13 days in the NDM bacterial infection group, 14 days in the other bacterial infection group, and 7 days in the COVID-19 only group. Comparing the COVID-19 with NDM infection and COVID-19 only groups, the adjusted model estimated a statistically significant hazard ratio of 0.28 (p = 0.002). Multivariate analysis revealed that age, APACHE II score, and CRP were predictors of mortality in all the patient groups. Conclusion: In patients treated for SARS-CoV-2 infection acquiring a bacterial infection due to prolonged hospitalization associated with the treatment of COVID-19 did not elevate mortality rates. The data suggests that in severe COVID-19 patients who survived beyond the first week of hospitalization, bacterial infections, particularly Klebsiella pneumoniae NDM, do not significantly impact mortality. Multivariate analysis revealed that age, APACHE II score, and CRP were predictors of mortality in all the patient groups.


Subject(s)
COVID-19 , Drug Resistance, Multiple, Bacterial , Intensive Care Units , Klebsiella Infections , Klebsiella pneumoniae , SARS-CoV-2 , beta-Lactamases , Humans , COVID-19/mortality , COVID-19/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/enzymology , Male , Female , Klebsiella Infections/mortality , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , Klebsiella Infections/epidemiology , beta-Lactamases/metabolism , beta-Lactamases/genetics , Middle Aged , Aged , Adult , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , Aged, 80 and over
20.
Front Cell Infect Microbiol ; 14: 1368923, 2024.
Article in English | MEDLINE | ID: mdl-38694516

ABSTRACT

Introduction: Diagnosing Mycoplasma faucium poses challenges, and it's unclear if its rare isolation is due to infrequent occurrence or its fastidious nutritional requirements. Methods: This study analyzes the complete genome sequence of M. faucium, obtained directly from the pus of a sternum infection in a lung transplant patient using metagenomic sequencing. Results: Genome analysis revealed limited therapeutic options for the M. faucium infection, primarily susceptibility to tetracyclines. Three classes of mobile genetic elements were identified: two new insertion sequences, a new prophage (phiUMCG-1), and a species-specific variant of a mycoplasma integrative and conjugative element (MICE). Additionally, a Type I Restriction-Modification system was identified, featuring 5'-terminally truncated hsdS pseudogenes with overlapping repeats, indicating the potential for forming alternative hsdS variants through recombination. Conclusion: This study represents the first-ever acquisition of a complete circularized bacterial genome directly from a patient sample obtained from invasive infection of a primary sterile site using culture-independent, PCR-free clinical metagenomics.


Subject(s)
Genome, Bacterial , High-Throughput Nucleotide Sequencing , Metagenomics , Mycoplasma , Humans , Metagenomics/methods , Mycoplasma/genetics , Mycoplasma/isolation & purification , Mycoplasma/classification , Mycoplasma Infections/microbiology , Mycoplasma Infections/diagnosis , Whole Genome Sequencing/methods , Lung Transplantation , Prophages/genetics , Interspersed Repetitive Sequences/genetics , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...